MicroRNA-18a-5p Administration Suppresses Retinal Neovascularization by Targeting FGF1 and HIF1A
In conclusion, miR-18a-5p may be a useful drug target for pathologic ocular neovascularization.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Blindness | Diabetes | Drugs & Pharmacology | Endocrinology | Genetics | Opthalmology | Study | Vitamin A